Your session is about to expire
← Back to Search
Stereotactic Radiosurgery for Brain Metastases
Study Summary
This trial is testing whether fractionated stereotactic radiosurgery (FSRS) is a feasible treatment option for people with no prior whole brain radiation.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have four or more new lesions.I need surgery for my main cancer lesion because it's causing symptoms.I have had surgery to remove a specific tumor.I have had whole brain radiation therapy before.I have a primary brain tumor.My cancer is either lymphoma, leukemia, multiple myeloma, or a germ cell tumor.I am 18 years old or older.I have had chemotherapy or targeted therapy before.My primary cancer is not in the brain.I have a tumor between 3cm and 5cm suitable for targeted radiation therapy.I am currently taking steroids or anti-epileptic medication.I am expected to live at least 12 weeks and can care for myself with some assistance.I have not had radiation treatment to my brain.I don't need a biopsy to prove I have brain metastases.I have 3 or fewer distinct brain lesions.My additional cancer spots will be treated with a one-time targeted radiation.
- Group 1: Fractionated Stereotactic Radiosurgery
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many test subjects are participating in this experiment?
"Affirmative. Clinicaltrials.gov reveals that this trial is still open for recruitment, with the first listing being posted on July 1st 2013 and its most recent update occurring on February 10th 2022. 25 people are needed from a single clinical site."
Are there any remaining opportunities to participate in this clinical trial?
"Affirmative. Information available on clinicaltrials.gov establishes that this medical trial is actively recruiting participants, with the initial post dating back to July 1st 2013 and last updated February 10th 2022. This study seeks 25 patients from a single site."
Share this study with friends
Copy Link
Messenger